Delivery Order SPE2DB20D7059-SPE2DB25FQEH7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,956.49 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $8,692.54, with completion scheduled for April 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $2,266.83, with completion scheduled for September 16, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order for pharmaceutical products to support federal medical procurement needs. The award was issued on September 15, 2025, with performance based in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $11,693.30 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on April 22, 2025, with completion expected by April 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $5,473.10 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens. This contract, which employs firm fixed-price pricing with no set-aside designation, represents a competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order is scheduled for completion by June 20, 2025, with performance to be executed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,907.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 18, 2025. This competitively awarded, firm fixed price delivery order is scheduled for completion by July 21, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract involves no set-aside designation and is issued as a child order under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency awarded a $1,550.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 19, 2025, with completion scheduled for August 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 and extends through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $18,021.64 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on June 17, 2025, with completion scheduled for June 18, 2025. This firm fixed-price, competitively awarded delivery order draws from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion and extends through December 2026. The pharmaceutical distributor will...
- The Defense Logistics Agency awarded a $36.6K delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 27, 2025, with completion targeted for August 28, 2025. This is a firm fixed-price, non-competitive set-aside delivery order performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's substantial indefinite delivery contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $13,633.82 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on April 24, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQEH7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on April 21, 2025, with completion scheduled for April 22, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement with performance based in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of medical product deliveries through DLA's Medical Supply Chain, including diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. This specific delivery order for Trulicity, a diabetes medication, reflects the company's ongoing role in supporting the Defense Health Agency and other government healthcare systems. The delivery order demonstrates the operational flexibility and responsiveness of AmerisourceBergen's prime vendor arrangement, which allows rapid fulfillment of medical supply requirements across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 4/21/25 |